Table 10.
Normalised mean fold change in serum liver function markers by week 4 (NΔ0–4), and week 8 (NΔ0–8).
| NΔ0–4 | NΔ0–8 | |||||
|---|---|---|---|---|---|---|
| Variable | PL | dGTE | dGTE+ | PL | dGTE | dGTE+ |
| ALT (U·L−1) | −0.06 ± 0.12 | −0.15 ± 0.04 | +0.11 ± 0.10 | −0.15 ± 0.06 | +0.01 ± 0.06 | +0.11 ± 0.07 * |
| AST (U·L−1) | +0.49 ± 0.62 | −0.12 ± 0.09 | +0.02 ± 0.11 | −0.09 ± 0.10 | +0.08 ± 0.05 | +0.10 ± 0.12 |
| ALP (U·L−1) | −0.01 ± 0.02 | +0.00 ± 0.03 | +0.02 ± 0.02 | −0.09 ± 0.04 | −0.02 ± 0.03 | −0.05 ± 0.02 |
| Bilirubin (µmol·L−1) | −0.02 ± 0.14 | +0.07 ± 0.13 | +0.02 ± 0.11 | +0.08 ± 0.15 | +0.09 ± 0.15 | +0.14 ± 0.09 |
PL = placebo; dGTE = decaffeinated green tea extract; dGTE+ = decaffeinated green tea extract with antioxidants. * denotes significantly different to PL (p = 0.015).